A phase III trial comparing UFT+PSK [tegafur/uracil + polysaccharide K] to UFT+LV [folinic acid] in stage IIB, III colorectal cancer

Trial Profile

A phase III trial comparing UFT+PSK [tegafur/uracil + polysaccharide K] to UFT+LV [folinic acid] in stage IIB, III colorectal cancer

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Aug 2015

At a glance

  • Drugs Polysaccharide K (Primary) ; Tegafur/uracil (Primary) ; Folinic acid
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 26 Feb 2009 Planned end date changed from 1 Apr 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov.
    • 17 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top